A Tale of Two Companies: Bayer’s Biodiversity Conundrum with Monsanto

In 2018, Bayer acquired the US agrochemical and agricultural chemicals company Monsanto. However, the deal, valued at around USD 64 billion, raised a number of questions. As a result of the merger, Bayer has since found itself responsible for a number of controversial practices of the US company. This is associated not only with sustainability risks but also with a potential risk of billions through various class actions.